China · 
Who invested in EpimAB Biotherapeutics?
EpimAB Biotherapeutics's investors include Sherpa Healthcare Partners, SDIC Fund and SCVC. Sherpa Healthcare Partners led its latest round.
China · Series B startup
Who invested in EpimAB Biotherapeutics
Funding summaryUpdated 26 Oct 2026
$74Mraised across 1 round since 2019, from 1 source
- Latest round
- Series B, $74MJun 2019
- Led by
- Sherpa Healthcare Partners and SDIC Fund
- Investors
- 3 (2 led)
The rounds
- Jun 2019
Everyone who backed them
Sherpa Healthcare PartnersVC firm1round, led 1
SDIC Fundno record of our own yet1round, led 1
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists EpimAB Biotherapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about EpimAB Biotherapeutics
How much has EpimAB Biotherapeutics raised?
EpimAB Biotherapeutics has raised $74M across 1 round since 2019.
When did EpimAB Biotherapeutics last raise?
EpimAB Biotherapeutics's most recent round was a Series B of $74M in Jun 2019, led by Sherpa Healthcare Partners.
What was EpimAB Biotherapeutics's biggest round?
Its most recent round, $74M in Jun 2019, is also its largest on record.
Who backed EpimAB Biotherapeutics first?
EpimAB Biotherapeutics's first round on record, in Jun 2019, was backed by Sherpa Healthcare Partners, SDIC Fund and SCVC.
What stage is EpimAB Biotherapeutics at?
EpimAB Biotherapeutics's latest named round is a Series B, in Jun 2019.
Where is EpimAB Biotherapeutics based?
EpimAB Biotherapeutics is based in China.
Who led EpimAB Biotherapeutics's rounds?
Sherpa Healthcare Partners led the Series B in 2019.
Companies like EpimAB Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.